TLR2 and hepatocellular carcinoma: Indeed, NAC treatment led to significantly less numbers, smaller volume and sizes of HCC in the DEN-injured liver from TLR2−/− mice when compared to the untreated TLR2−/− mice (Figure 4A–E).